G Perani
- Nephrology top 5%
- Biochemistry top 5%
- Antioxidant Activity and Oxidative Stress 3
- Transplantation top 10%
- Clinical Biochemistry top 10%
-
- Blood Pressure and Hypertension Studies 4
-
- Lipoproteins and Cardiovascular Health 5
-
- Hormonal Regulation and Hypertension 5
-
- Cancer, Lipids, and Metabolism 3
-
- Hepatitis C virus research 3
-
- Ovarian function and disorders 2
-
- Liver Disease Diagnosis and Treatment 2
- Co-authors
- Francesco FalaschiG FinardiElena MaggiAntonietta GazoRiccardo BellazziMario RegazziAntonello GavazziCarlo Campana
- Partner nations
- ItalyFranceNetherlands
In The Last Decade
G Perani
31 papers receiving 689 citations
Peers
Comparison fields: 5 of 88
- Nephrology 143
- Biochemistry 100
- Transplantation 28
- Clinical Biochemistry 68
- Cardiology and Cardiovascular Medicine 182
Countries citing papers authored by G Perani
This map shows the geographic impact of G Perani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Perani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Perani more than expected).
Fields of papers citing papers by G Perani
This network shows the impact of papers produced by G Perani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Perani. The network helps show where G Perani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G Perani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 9 | |
| 2 | 2014 | 32 | |
| 3 | 2000 | 86 | |
| 4 | 1999 | 8 | |
| 5 | Lipoproteine ossidate e aterogenesi. | 1996 | 1 |
| 6 | 1996 | 11 | |
| 7 | 1996 | 64 | |
| 8 | Clinical efficacy and pharmacokinetics of HMG-CoA reductase inhibitors in heart transplant patients treated with cyclosporin A. | 1994 | 18 |
| 9 | 1994 | 233 | |
| 10 | [Autoantibodies against oxidised low density lipoproteins in patients with coronary disease]. | 1994 | 21 |
| 11 | 1992 | 12 | |
| 12 | 1991 | 9 | |
| 13 | 1991 | 15 | |
| 14 | 1990 | 8 | |
| 15 | Ipercolesterolemia e parametri emoreologici. | 1989 | 0 |
| 16 | High-density lipoprotein cholesterol increase in hypertensive patients treated with the calcium channel blocker tiapamil | 1989 | 1 |
| 17 | Effects of nisoldipine treatment on plasma lipoproteins | 1987 | 4 |
| 18 | [Changes in post-heparin liprotein lipase activity after testosterone treatment]. | 1978 | 1 |
| 19 | Studies on the antitumoral activity of the biguanides. V. | 1968 | 2 |
| 20 | 1960 | 18 |
About G Perani
G Perani is a scholar working on Hepatology, Biochemistry and Endocrinology, Diabetes and Metabolism, having authored 34 papers that have together received 738 indexed citations. Recurring topics across this work include Lipoproteins and Cardiovascular Health (5 papers), Hormonal Regulation and Hypertension (5 papers), Blood Pressure and Hypertension Studies (4 papers), Cancer, Lipids, and Metabolism (3 papers), Hepatitis C virus research (3 papers), Antioxidant Activity and Oxidative Stress (3 papers), Ovarian function and disorders (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Nephrology (143 citations), Biochemistry (100 citations) and Transplantation (28 citations). G Perani has collaborated with scholars based in Italy, France and Netherlands. Frequent co-authors include Francesco Falaschi, G Finardi, Elena Maggi, Antonietta Gazo, Riccardo Bellazzi, Mario Regazzi, Antonello Gavazzi, Carlo Campana, I Iacona and Alessandra Martignoni.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.